Peptides
Since the outbreak of the SARS-CoV-2, the spread of COVID-19 and its impact on public health have continued to ferment. Elabscience® is committed to providing high-quality SARS-COV-2 (2019-nCoV) research related peptides for global scientific research institutions.
In view of the hot targets, the Elabscience® expert team has designed and synthesized the SARS-COV-2 (2019-nCoV) related peptide, providing comprehensive support.
You can choose peptide synthesis, peptide library or peptide pool for delivery according to your scientific research. For more information, please contact us:techsupport@elabscience.com
In stock SARS-CoV-2 peptides pools
| Product Name | Size | Purity | Manual |
|---|---|---|---|
| SARS-CoV-2 Spike Glycoprotein-crude (B.1.1.529-Omicron) | 2 Vials (25 µg/ peptide) | Crude (Major peak by ESI-MS is guaranteed to be peptide of interest - determined at 220 nm for each individual peptide). | |
| SARS-CoV-2 Spike Glycoprotein-crude | 2 Vials (25 μg/ peptide) | ||
| SARS-CoV-2 M | 1 Vials (25 μg/ peptide) | ||
| SARS-CoV-2 N | 1 Vials (25 μg/ peptide) |
| Product | Peptides | Protein Sequence |
|---|---|---|
| HCoV-229E Spike Glycoprotein |
291 polypeptides |
|
| HCoV-OC43 Spike Glycoprotein |
336 polypeptides |
|
| SARS-CoV-2 ORF3a |
66 polypeptides |
|
| SARS-CoV-2 ORF6 |
13 polypeptides |
|
| SARS-CoV-2 ORF7a |
28 polypeptides |
|
| SARS-CoV-2 ORF7b |
8 polypeptides |
|
| SARS-CoV-2 ORF8 |
28 polypeptides |
|
| SARS-CoV-2 ORF9b |
22 polypeptides |
|
| SARS-CoV-2 ORF10 |
7 polypeptides |
|
| SARS-CoV-2 Spike Glycoprotein |
315 polypeptides |
|
| SARS-CoV-2 N |
102 polypeptides |
|
| SARS-CoV-2 E |
16 polypeptides |
|
| SARS-CoV-2 M |
53 polypeptides |
|
| SARS-CoV-2 Y14 |
16 polypeptides |
★Design Principles--Each peptide contains 15aa, 11aa overlapping